A detailed history of Alta Advisers LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alta Advisers LTD holds 3,600 shares of GILD stock, worth $317,088. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,600
Previous 3,600 -0.0%
Holding current value
$317,088
Previous $263,000 6.46%
% of portfolio
0.12%
Previous 0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 28, 2022

BUY
$59.54 - $68.01 $214,344 - $244,836
3,600 New
3,600 $222,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.